- Home
- GHY vs PACB Comparison
GHY vs PACB Comparison
Compare GHY & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHY
- PACB
- Stock Information
- Founded
- GHY 2012
- PACB 2000
- Country
- GHY United States
- PACB United States
- Employees
- GHY N/A
- PACB N/A
- Industry
- GHY Trusts Except Educational Religious and Charitable
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- GHY Finance
- PACB Industrials
- Exchange
- GHY Nasdaq
- PACB Nasdaq
- Market Cap
- GHY 521.4M
- PACB 452.1M
- IPO Year
- GHY N/A
- PACB 2010
- Fundamental
- Price
- GHY $12.35
- PACB $1.60
- Analyst Decision
- GHY
- PACB Buy
- Analyst Count
- GHY 0
- PACB 15
- Target Price
- GHY N/A
- PACB $2.92
- AVG Volume (30 Days)
- GHY 184.8K
- PACB 11.4M
- Earning Date
- GHY 01-01-0001
- PACB 11-07-2024
- Dividend Yield
- GHY 10.58%
- PACB N/A
- EPS Growth
- GHY N/A
- PACB N/A
- EPS
- GHY N/A
- PACB N/A
- Revenue
- GHY N/A
- PACB $173,147,000.00
- Revenue This Year
- GHY N/A
- PACB N/A
- Revenue Next Year
- GHY N/A
- PACB $25.88
- P/E Ratio
- GHY N/A
- PACB N/A
- Revenue Growth
- GHY N/A
- PACB 2.14
- 52 Week Low
- GHY $10.24
- PACB $1.16
- 52 Week High
- GHY $11.92
- PACB $10.65
- Technical
- Relative Strength Index (RSI)
- GHY 37.10
- PACB 36.99
- Support Level
- GHY $12.48
- PACB $1.82
- Resistance Level
- GHY $13.11
- PACB $2.66
- Average True Range (ATR)
- GHY 0.17
- PACB 0.34
- MACD
- GHY -0.03
- PACB -0.08
- Stochastic Oscillator
- GHY 13.20
- PACB 3.02
About GHY PGIM Global High Yield Fund Inc.
PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.